Can existing unrelated vaccines boost a COVID-19 vaccine prime?

Can existing unrelated vaccines boost a COVID-19 vaccine prime?

Bibliographic Details
Main Authors:	Nathaniel Hupert, Daniela Marín-Hernández, Douglas F. Nixon
Format:	Article
Language:	English
Published:	Elsevier 2021-02-01
Series:	EClinicalMedicine
Online Access:	http://www.sciencedirect.com/science/article/pii/S2589537021000389

Similar Items

Heterologous vaccine interventions: boosting immunity against future pandemics
by: Daniela Marín-Hernández, et al.
Published: (2021-05-01)

Vaccinating the world against COVID-19: getting the delivery right is the greatest challenge
by: Nathaniel Hupert, et al.
Published: (2021-03-01)

Modeling the effect of boost timing in murine irradiated sporozoite prime-boost vaccines.
by: Cristina Fernandez-Arias, et al.
Published: (2018-01-01)

Investigating Prime-Pull Vaccination through a Combination of Parenteral Vaccination and Intranasal Boosting
by: Carla B. Roces, et al.
Published: (2019-12-01)

P19-58 LB. Comparison of the immunogenicity in humans and rhesus macaques of vaccines consisting of DNA priming and MVA boosting and MVA priming and boosting
by: Wyatt LS, et al.
Published: (2009-10-01)

Modeling the Dependence of Immunodominance on T Cell Dynamics in Prime-Boost Vaccines
by: Clemente Fernandez Arias, et al.
Published: (2021-12-01)

Heterologous prime-boost vaccine regimens against Chlamydia trachomatis
by: Badamchi-Zadeh, Alexander
Published: (2014)

Can Complementary Prime-Boost Immunization Strategies Be an Alternative and Promising Vaccine Approach Against Dengue Virus?
by: Iris Valdés, et al.
Published: (2019-08-01)

Heterologous Ad26.COV2.S Prime and mRNA-Based Boost COVID-19 Vaccination Regimens: The SWITCH Trial Protocol
by: Roos S. G. Sablerolles, et al.
Published: (2021-09-01)

848 Prime-boost vaccination for the treatment of triple negative breast cancer
by: Christine Lawson, et al.
Published: (2020-11-01)

Determination of optimal prime-boost vaccination regimens against zaire ebolavirus
by: Aviles, Jenna
Published: (2013)

Determination of optimal prime-boost vaccination regimens against zaire ebolavirus
by: Aviles, Jenna
Published: (2013)

Heterologous prime-boost strategies in the development of novel vaccines against leishmaniasis
by: Lange, Uta Gisela
Published: (2003)

Extreme immunotherapy: emergency immunology to defeat pandemics
by: Douglas F. Nixon, et al.
Published: (2021-09-01)

P15-14. Assuring data quality of the phase III vaccine trial of ALVAC vaccine priming and AIDSVAX vaccine boosting in Thailand
by: Kunasol P, et al.
Published: (2009-10-01)

Can technology increase COVID-19 vaccination rates?
by: The Lancet Digital Health
Published: (2021-05-01)

Characterisation of heterologous prime-boost vaccination strategies : an investigation into the nature and delivery of vaccines and the subsequent generation of immune responses
by: Searle, Benjamin James
Published: (2004)

Immunogenicity of Low-Dose Prime-Boost Vaccination of mRNA Vaccine CV07050101 in Non-Human Primates
by: Neeltje van Doremalen, et al.
Published: (2021-08-01)

Dual-Antigen COVID-19 Vaccine Subcutaneous Prime Delivery With Oral Boosts Protects NHP Against SARS-CoV-2 Challenge
by: Elizabeth Gabitzsch, et al.
Published: (2021-09-01)

Prime-boost AIDS Vaccine Strategies Based on Replication-Competent Adenovirus Recombinants
by: Srivastava Indresh, et al.
Published: (2005-12-01)

Exploring heterologous prime-boost vaccination approaches to enhance influenza control in pigs
by: Chong Li, et al.
Published: (2020-07-01)

Short or Long Interval between Priming and Boosting: Does It Impact on the Vaccine Immunogenicity?
by: Elena Pettini, et al.
Published: (2021-03-01)

T-cell-mediated cross-strain protective immunity elicited by prime–boost vaccination with a live attenuated influenza vaccine
by: Junwei Li, et al.
Published: (2014-10-01)

Biomaterials and Oxygen Join Forces to Shape the Immune Response and Boost COVID‐19 Vaccines
by: Thibault Colombani, et al.
Published: (2021-09-01)

The COVID-19 Pandemic: Can it Play a Role in Vaccine Acceptance or Contribute to Vaccine Hesitancy?
by: Marta Valente Pinto
Published: (2020-07-01)

Heterologous Prime-Boost HIV-1 Vaccination Regimens in Pre-Clinical and Clinical Trials
by: Julia L. Hurwitz, et al.
Published: (2010-02-01)

Optimize Prime/Boost Vaccine Strategies: Trained Immunity as a New Player in the Game
by: Jean-Louis Palgen, et al.
Published: (2021-03-01)

COVID-19 vaccine – technical aspects of vaccination
by: Jaciubek Marzena, et al.
Published: (2021-03-01)

Could an Unrelated Live Attenuated Vaccine Serve as a Preventive Measure To Dampen Septic Inflammation Associated with COVID-19 Infection?
by: Paul L. Fidel, et al.
Published: (2020-06-01)

Pan-Influenza A Protection by Prime–Boost Vaccination with Cold-Adapted Live-Attenuated Influenza Vaccine in a Mouse Model
by: Yo Han Jang, et al.
Published: (2018-02-01)

COVID-19 vaccines
by: Cenk Demirdover
Published: (2021-01-01)

Intranasal plus subcutaneous prime vaccination with a dual antigen COVID-19 vaccine elicits T-cell and antibody responses in mice
by: Adrian Rice, et al.
Published: (2021-07-01)

SOCIAL REPRESENTATIONS ON VACCINES AND VACCINATION AGAINST COVID 19
by: Valeria Fernanda Altamirano, et al.
Published: (2021-09-01)

COVID-19 vaccine hesitancy and patient self-advocacy: a statistical analysis of those who can and can’t get vaccinated
by: Ashwell, D., et al.
Published: (2022)

Immunogenicity and protective efficacy of prime-boost immunization in mice vaccinated with live and inactivated influenza A (H5N1) vaccines
by: I. Losev, et al.
Published: (2019-05-01)

Study on the immunogenicity of DNA prime-adenovirus boost immunization of cervical cancer vaccine in the mouse model
by: Chu Chi Lin, et al.
Published: (2017)

Oncolytic Rhabdovirus Vaccine Boosts Chimeric Anti-DEC205 Priming for Effective Cancer Immunotherapy
by: Fanny Tzelepis, et al.
Published: (2020-12-01)

Heterologous Prime Boost Vaccination Induces Protective Melanoma-Specific CD8+ T Cell Responses
by: Sandra S. Ring, et al.
Published: (2020-12-01)

Multiserotype protection elicited by a combinatorial prime-boost vaccination strategy against bluetongue virus.
by: Eva Calvo-Pinilla, et al.
Published: (2012-01-01)

Accelerated heterologous prime-boost adenovirus vector-based SIV vaccine in neonatal rhesus monkeys
by: Liu J, et al.
Published: (2012-09-01)